GlassScriptPhysician profile
Stephanie Carter
NPI 1104888973
$3,901.77
in general payments reported to CMS, 2019-2025
44 companies · $692 in 2025
The $692 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,280 · 2020: $602 · 2021: $129 · 2022: $26.03 · 2023: $378 · 2024: $795 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $607.63 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $457.43 | 2019-2025 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $380.47 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $243.40 | 2024-2025 | |
| Amgen INC. | $184.11 | 2019-2025 | Otezla, Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $170.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $168.07 | 2019-2025 | |
| Medtronic, INC. | $138.37 | 2025 | Inceptiv, Intellis Adaptivestim |
| Astellas Pharma US INC | $116.48 | 2019-2025 | Veozah, Myrbetriq |
| E.R. Squibb & Sons, L.L.C. | $97.27 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $88.99 | 2019-2020 | |
| Abbott Laboratories | $88.83 | 2019-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $86.37 | 2019-2020 | |
| Amarin Pharma, INC. | $77.75 | 2019-2020 | |
| Exact Sciences Corporation | $73.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.